These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 20035998

  • 1. A molecular receptor targeted, hydroxyapatite nanocrystal based multi-modal contrast agent.
    Ashokan A, Menon D, Nair S, Koyakutty M.
    Biomaterials; 2010 Mar; 31(9):2606-16. PubMed ID: 20035998
    [Abstract] [Full Text] [Related]

  • 2. Folate receptor targeted, rare-earth oxide nanocrystals for bi-modal fluorescence and magnetic imaging of cancer cells.
    Setua S, Menon D, Asok A, Nair S, Koyakutty M.
    Biomaterials; 2010 Feb; 31(4):714-29. PubMed ID: 19822364
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Folate targeted polymeric 'green' nanotherapy for cancer.
    Narayanan S, Binulal NS, Mony U, Manzoor K, Nair S, Menon D.
    Nanotechnology; 2010 Jul 16; 21(28):285107. PubMed ID: 20585151
    [Abstract] [Full Text] [Related]

  • 7. Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.
    Schroeder JE, Shweky I, Shmeeda H, Banin U, Gabizon A.
    J Control Release; 2007 Dec 04; 124(1-2):28-34. PubMed ID: 17928088
    [Abstract] [Full Text] [Related]

  • 8. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications.
    Lin JJ, Chen JS, Huang SJ, Ko JH, Wang YM, Chen TL, Wang LF.
    Biomaterials; 2009 Oct 04; 30(28):5114-24. PubMed ID: 19560199
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
    Ahrén M, Selegård L, Klasson A, Söderlind F, Abrikossova N, Skoglund C, Bengtsson T, Engström M, Käll PO, Uvdal K.
    Langmuir; 2010 Apr 20; 26(8):5753-62. PubMed ID: 20334417
    [Abstract] [Full Text] [Related]

  • 15. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
    Yang H, Zhuang Y, Sun Y, Dai A, Shi X, Wu D, Li F, Hu H, Yang S.
    Biomaterials; 2011 Jul 20; 32(20):4584-93. PubMed ID: 21458063
    [Abstract] [Full Text] [Related]

  • 16. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
    Chiu SJ, Marcucci G, Lee RJ.
    Anticancer Res; 2006 Jul 20; 26(2A):1049-56. PubMed ID: 16619505
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Blood compatibility of iron-doped nanosize hydroxyapatite and its drug release.
    Chandra VS, Baskar G, Suganthi RV, Elayaraja K, Joshy MI, Beaula WS, Mythili R, Venkatraman G, Kalkura SN.
    ACS Appl Mater Interfaces; 2012 Mar 20; 4(3):1200-10. PubMed ID: 22316071
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.